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Synaptotagmins are two C2 domain-containing transmembrane proteins. The function of calcium-
sensitive members in the regulation of post-Golgi trafﬁc has been well established whereas little
is known about the calcium-insensitive isoforms constituting half of the protein family. Novel bind-
ing partners of synaptotagmin 11 were identiﬁed in b-cells. A number of them had been assigned
previously to ER/Golgi derived-vesicles or linked to RNA synthesis, translation and processing.
Whereas the C2A domain interacted with the Q-SNARE Vti1a, the C2B domain of syt11 interacted
with the SND1, Ago2 and FMRP, components of the RNA-induced silencing complex (RISC). Binding
to SND was direct via its N-terminal tandem repeats. Our data indicate that syt11 may provide a link
between gene regulation by microRNAs and membrane trafﬁc.
Structured summary of protein interactions:
Syt11C2A physically interacts with Vti1a by pull down (View interaction)
Syt11C2B physically interacts with SND1, PDIA6, Vti1b, Vti1a, Ago2 and FMRP by pull down
(View interaction)
syt11C2B binds to SND1 by ﬁlter binding (View interaction)
Syt11C2B physically interacts with EIF3A, PDIA6, NPM1, EIF3B, NCL, RS3, RS3A, CBR1, ANP32B,
LOC683961, SET, SND1, TBB2C, RS10 and RS18 by pull down (View interaction)
SND1 physically interacts with Ago2 by anti bait coip (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A number of transmembrane proteins are implicated in the
transport, docking and fusion of vesicles during intracellular
transport. Members of the synaptotagmin family (syts) have been
shown to form calcium sensors in diverse trafﬁcking pathways [1].
They share a common structure: a short intra luminal N-terminal
domain, a single transmembrane domain and a cytoplasmic car-
boxy-terminal domain. In addition to this topology, synaptotagmins
exhibit two C2 domains in their cytoplasmic tail. Synaptotagminsare either Ca2+-sensitive or -insensitive according to their capacity
to bind the divalent ion and phospholipids via these C2 domains,
referred to as C2A and C2B. The C2 domains may act as independent
modules and their respective relevance and physiological targets
are still not completely resolved. In addition to their role as
Ca2+-dependent trigger in membrane fusion, they may also partici-
pate in vesicle-membrane interactions [2].
The superfamily of synaptotagmins currently contains 17
isoforms in mammals which can be classiﬁed according to their
biochemical properties or sequence alignments [1,3]. Syt1 to 3, 5
to 7, 9 and 10 are grouped in regard to their ability to bind
phospholipids in a calcium-dependent manner suggesting an
involvement of these isoforms in Ca2+-regulated membrane fusion.
On the contrary, syt4, syt8 and syt11 to 15 do not exhibit calcium-
sensitivity [4–10]. The biochemical properties of syt16 and 17 are
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independent functions. Thus, function of several Ca2+-sensitive iso-
forms have been characterized in detail in post-Golgi trafﬁcking,
whereas the localization and the biological role of most other iso-
forms are still poorly understood. In the attempt to characterize
the role of synaptotagmins in the exocytosis of large dense core
vesicles, we and others have been able to assign a role to syt1, 2,
7 and 9 using endocrine b-cells as a model system [11–16].
In contrast, the role and distribution of the Ca2+-insensitive
forms are still largely unknown although they constitute about a
half of this protein family. In this setting, syt11 is of particular
interest. Altered expression patterns have been associated with
type 2 diabetes and with Parkinson’s disease [17,18]. This protein
appears as a syt4 paralog in vertebrates [3] and Ca2+-sensitivity
has been lost due to mutation of key amino acids representing
an evolutionary adaptation [4]. Thus, knowledge about this isoform
may contribute to elucidate the panel of functions of synaptotag-
mins beyond calcium sensing in membrane fusion. In the absence
of any known or predictable cellular function, we decided to inves-
tigate its binding partners in the well-established model of insulin-
secreting b-cells.
2. Materials and methods
2.1. Materials
The following commercial monoclonal antibodies were
employed: anti-Vti1b and anti-Vti1a (Transduction Laboratories);
anti-insulin (Sigma–Aldrich); anti- bCOP (Sigma–Aldrich), anti-
AP1-AP2 (Sigma–Aldrich); (Transduction Laboratories); anti-GST
(Sigma–Aldrich); anti-glucagon (Sigma–Aldrich). The following
commercial polyclonal antibodies were used: guinea pig anti-
SND1 (Progen), guinea pig anti-insulin (Sigma–Aldrich), rabbit
anti-Ago2 (Cell Signalling) and rabbit polyclonal anti-FMRP
(Abcam). The following secondary antibodies were employed:
HRP-conjugated secondary antibodies (GEHealthcare). Several anti-
bodies were kindly donated: the monoclonal anti-FMRP antibody
1C3 (Dr. Mazroui, Université Laval, Québec, Canada); a rabbit
polyclonal anti-CaBP1/PDIA6 (Dr. Nguyen Van, Universität
Göttingen, Germany), a monoclonal anti-Ago2 (851) (Dr. Hobman,
University of Alberta, Edmonton, Canada), a monoclonal anti-EEA1
(Dr. Grunberg, Genève, Switzerland), a monoclonal anti-LAMP1
(Dr. Malosio, Milano), a rabbit polyclonal anti-syntaxin5, anti-
syntaxin18 and anti-D12/Use1p (Dr. Hatsuzawa, Fukushima
Medical University, Japan). The rabbit polyclonal anti SND1/p102
had been described previously [19].
2.2. Plasmids
cDNA encodingmouse syt11was generated byRT-PCR from total
brain RNA and inserted in a pGEM-T cloning vector as described in
[6]. Truncated syt11 were obtained by PCR on pGEM-T-Syt11 using
the following primers: syt11C2A (amino acids 150–264), sense
primer: CGCGGATCCTCGCCAGAGGAAGAG and antisense primer:
CCGGAATTCTTACAATGGCACCATGAC; syt11 C2B (amino acids
265–430), sense primer: CGCGGATCCGCTGGAGTGGACCCC and
antisense primer: CCGGAATTCTTAGTACTCGCTCAG. PCR fragments
were then digested with BamHI and EcoRI and inserted in the
pGEX-2T vector (GE Healthcare) allowing the expression of a
N-terminal GST fusion protein. Plasmids encoding the cytoplasmic
portions of synaptotagmins fused to GST were as described [6].
The plasmid pGEX-4T-1-p100-SN(1-4), containing the four
N-terminal SN-like domains of SND1 (amino acids 1–639), were
kindly provided by Dr. O. Silvennoinen (University of Tampere,
Finland) [20].2.3. Cell culture, ﬂuorescence microscopy and immunoprecipitation
INS-1E were cultured as previously described [21]. Islets were
isolated from adult male Wistar rats (Iffa Credo, Lyon, France)
using collagenase digestion and separation on a Ficoll density
gradient [22]. For immunoﬂuorescence studies, isolated cells from
islets were obtained after dissociation with 0.025% trypsin/
0.27 mM EDTA and then cultured in complete RPMI-1640 medium
containing 5.6 mM glucose for 1 week. Islet cells were seeded on
poly-L-lysine (Sigma–Aldrich) coated Lab-Tek Chamber Slide™
System. After ﬁxation with 2% paraformaldehyde for 20 min, cells
were permeabilised for 5 min in 0.1% Triton X-100 and blocked
in 2% BSA. Stained cells were mounted in Citiﬂuor (Citiﬂuor LTD,
London, UK) and observed with the BioRad confocal microscope
equipped with an argon-krypton laser.
Postnuclear supernatants (PNS) from INS-1E cells were
prepared as described in [23]. PNS were then centrifuged at
100,000g, 2 h, 4 C to obtain the membrane fraction. Triton X-100
extracts were obtained as described previously [23,24] except that
sonication was omitted. Immunoprecipitation was performed on
solubilized fractions by adding the relevant antibody and a 50%
suspension of protein A-Sepharose beads CL-4B (GE Healthcare)
for 2 h at 4 C. Beads were washed several times, resuspended in
Laemmli buffer and supernatants subsequently analyzed by
SDS–PAGE and immunoblots as published [12]. To test speciﬁcity,
anti-syt11 antibodies were preabsorbed prior to immunoblot with
antigenic peptide (10–50 lM) for 1 h at room temperature.
2.4. Puriﬁcation of recombinant proteins, pull-down experiments and
direct binding assay
GST-Syt fusion proteins were expressed as described [24].
Recombinant proteins were either eluted directly or after over-
night cleavage at 4 C from the GST-tag by 4 U/ml of thrombin
(GE Healthcare). The pGEX-4T1-p100-SN (1–4) expression vector
was kindly donated by Dr. Valineva (University of Tampere, Fin-
land). This construct was expressed in Rosetta host strain (Nova-
gen) under the same conditions as for other GST-tagged proteins.
Puriﬁed recombinant proteins were analyzed by Coomassie blue
stained SDS–PAGE.
25 lg of GST fusion-proteins were immobilized onto gluthati-
one-Sepharose beads in buffer A (20 mM MOPS, 250 mM sucrose,
5 mM MgCl2, pH 7). Beads were washed 4 times with buffer A/
1 M NaCl and once without buffer A alone. Immobilized fusion
proteins were subsequently treated for 10 min at 30 C with micro-
coccal nuclease (Calbiochem) at a ﬁnal concentration of 33 U/ml.
Beads were washed again in Buffer A/0.01% Triton X-100. 500 lg
of a freshly solubilized PNS was mixed with 25 lg of immobilized
GST fusion proteins. After incubation at 4 C for 2 h, beads were
washed twice with buffer A/0.1% Triton X-100, twice with buffer
A/300 mM KCl and ﬁnally with buffer A. Bound proteins were
eluted by adding Laemmli’s buffer. The eluted samples were
resolved by SDS–PAGE followed by spectrometric mass analysis
or by Western blot detection with the relevant antibodies.
Puriﬁed recombinant syt11C2A and syt11C2B (1 lg) were
directly spotted onto PVDF membranes, which were subsequently
washed in TBS (50 mM Tris, 190 mM NaCl, pH 8)-0.1% Tween and
blocked in TBS-1% BSA prior to incubation in 10 lg of puriﬁed
GST or GST-SN (N-terminal four staphylococcus nuclease domains
of SND1 fused to GST). Membranes were washed with TBS-Tween
and TBS, blocked in 5% milk TBS-Tween and incubated overnight
with a guinea pig anti-SND1 antibody (1/2000). After three washes
in TBS-Tween, blots were incubated for 1 h at room temperature
with HRP-conjugated anti-guinea pig IgG secondary antibody.
Binding of antibodies was visualized by chemiluminescence.
Fig. 1. Identiﬁcation of syt11 binding partners by GST pull-down experiments. (A)
Schematic representation of the GST-Syt11 constructs used. GST-Syt11C2A corre-
sponds to the GST protein fused to amino acids 150–264 of syt11 and GST-Syt11C2B
contains amino-acids 265–430. (B) Western-blots analysis of GST-pull-down
experiments. Puriﬁed recombinant proteins were incubated with INS-1E post-
nuclear supernatants and bound proteins were analyzed with appropriate anti-
bodies: guinea pig polyclonal anti-SND1 (1/1000), anti-PDIA6 (1/1000), anti-Vti1a
(1/2500), anti-Vti1b (1/500), anti-Ago2 (1/1000) and anti-FMRP (1/1000). Input
represents 3% of the starting material. (C) Quantiﬁcation of binding (N = 3–5).
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Selected bands were excised from gels and digested with tryp-
sin using standard protocols, the resulting peptide mixture being
analyzed by tandem MS (MS/MS). Data were acquired on a MALDI
Q-TOF Premier mass spectrometer used in MS/MS mode (Waters,
Manchester, UK), with a-cyano-4-hydroxy-cinnamic acid (Sigma–
Aldrich) used as a matrix (3.6 mg mL1 solution in 50% acetonitrile
in 0.1% aqueous triﬂuoroacetic acid). Mono-isotopic masses were
corrected using the pseudomolecular ion of Glu-Fibrinopeptide as
a lock mass (1570.6774 Da) [25]. Proteins were identiﬁed using
the MS/MS search module from the online version of MASCOT soft-
ware (http://www.matrixscience.com) against the non-redundant
protein NCBI or Swissprot database. The following parameters
were used: peptide charge +1, peptide tolerance ±0.03 Da, MS/MS
tolerance ±0.1 Da and one missed cleavage allowed for trypsin.
3. Results
To obtain information about the role of syt11 in b-cells, we
decided to search for protein–protein interactions. Synaptotagmins
contain two independent cytosolic modules, C2A and C2B, which
were fused separately to GST (Fig. 1A: GST-Syt11C2A, amino acids
150–264; GST-Syt11C2B, amino acids 265–430). Pull-down exper-
iments were performed using these constructs as baits for binding
partners in INS-1E cell extracts. No differences were observed
between GST alone and GST-Syt11C2A when used as bait and
bound proteins were separated and visualized by SDS/PAGE. In
contrast, using GST-Syt11C2B as bait, 15 distinct speciﬁc bands in
a molecular mass range from 17 to 160 kDa were detected in Coo-
massie blue-stained gels and further analyzed by mass spectrome-
try run onto a MALDI-Q-TOF used in MS/MS mode as given in
Table 1. Among the peptides identiﬁed, certain are part of proteins
known to be involved in the translation machinery such as eukary-
otic translation initiation factor 3 subunits A and B or subunits of
the 40S ribosomal complex (RS3A, RS3, RS10, RS13, RS18). Interest-
ingly, the staphylococcal nuclease domain-containing protein 1,
termed SND1 or p100 coactivator, was also identiﬁed as syt11-
binding protein via N-terminal and C-terminal peptides. SND1
has been implicated in various cell functions in addition to its role
as a transcriptional coactivator, namely in the secretion of lipid
droplets in mammary epithelial cells and hepatocytes [19,26,27]
and as part of the RISC complex by interacting with Argonaute 2
[28]. The protein is expressed in primary pancreatic a- and b-cells
(data not shown). In addition we noticed the presence of the pro-
tein disulﬁde-isomerase PDIA6 (also termed CaBP1 or ERP5), an
ER/ERGIC chaperone, of a carbonyl reductase ([NAPDH]1 or CBR1)
and of several proteins known for their distribution in the nucleus,
the cytosol, and endomembrane attachment.
To corroborate and extend these ﬁndings, pull-down experi-
ments using the C2A or the C2B domain of syt11 were performed
under the same conditions using cell extracts but analyzed by
immunoblotting. The strong signal observed with the anti-SND1
antibody conﬁrmed the interaction between GST-Syt11C2B and
SND1 already revealed by mass spectrometry (Fig. 1B and C). Sim-
ilarly, PDIA6 interacted only with GST-Syt11C2B but not with the
C2A domain of syt11. As synaptotagmins are involved in vesicular
trafﬁc we also examined potential interactions with SNARE pro-
teins and tested ﬁrst for SNARE proteins localized in the ER-Golgi
region of the cell. The C2B domain of syt11 exhibited clear interac-
tion with the SNARE protein Vti1b whereas Vti1a interacted mainly
with the C2A domain (Fig. 1B and C) suggesting a potential role of
syt11 in vicinity of the Golgi apparatus. However, interactions
were not detected with the ER SNARE proteins D12/Use1p and syn-
taxin 18 or with the Golgi SNARE syntaxin 5 (Data not shown).Similarly, we did not ﬁnd any evidence for interactions for a num-
ber of other proteins such as b-COP, a constituent of COPI vesicles,
the clathrin adapters AP1 and AP2 as well as the endoplasmic retic-
ulum chaperone BIP (data not shown). As syt11 interacts with
SND1, which is part of the RISC complex, we also tested for the
presence of fragile X mental retardation protein (FMRP) and the
endonuclease Argonaute2 (Ago2), known binding partners of
SND1 [28]. Indeed both were found in the speciﬁc eluate, but only
in the case of syt11C2B (Fig. 1B and C).
Unfortunately the distribution of syt11 along the secretory
pathway could not been determined. Indeed, several commercial
as well as antibodies generated in our or other laboratories were
non-speciﬁc. Although they bound to recombinant syt11 and their
binding was reduced or abolished by an excess of peptide, we did
not observe any change in intensity after proven and substantial
knock-down of syt 11 (data not shown).
To obtain further insight into the interaction with components
of RISC, we next examined the interaction of endogenous SND1 and
Ago2 by co-immunoprecipitation in INS-1E cells. For this purpose,
SND1 was immunoprecipitated from INS-1E cells using a poly-
clonal guinea pig antibody and analyzed by Western-blot using
Table 1
Proteomic analysis of syt11C2B binding partners.
Name NCBI Accession
number
MW MS/MS
peptides
Mascot
Score
Present on ERGIC,
Golgi or derived
vesicles
ANP32B Acidic leucine-rich nuclear phosphoprotein 32 family member
B
gi|18777770 31.2 2 85
CBR1 Carbonyl reductase [NAPDH]1 gi|9506467 30.8 4 257
EIF3A Eukaryotic translation initiation factor 3 subunit 10 (theta) gi|149040541 163.5 3 49
Eukaryotic translation initiation factor 3 subunit A gi|261337190 163.5 3 49
ZH12 gi|95102034 150.4 3 49
EIF3B Eukaryotic translation initiation factor 3 subunit B gi|72255511 91.2 3 99
NCL Nucleolin gi|128844 77.1 3 141 a
NPM1 Nucleophosmin gi|7242160 32.7 2 104 a, b
Nucleolar protein B23.2 gi|203078 28.5 2 104
PDIA6 Calcium binding protein/Protein disulﬁde-isomerase A6
precursor
gi|488838 47.1 4 99 a, c
RS3 40S Ribosomal protein S3 gi|57164151 26.6 3 130 a, b
RS3A 40S Ribosomal protein S3a gi|8394221 30.1 1 58 b
RS10 40S Ribosomal protein S10-like gi|62652203 19.6 1 43 a, b
RS13 40S Ribosomal protein S13-like gi|109476367 17.8 1 44
RS18 40S Ribosomal protein S18-like gi|27658598 17.7 3 118 b
SET SET Protein gi|60499029 33.4 1 69 a
SND1 Staphylococcal nuclease domain-containing protein 1 gi|77404395 102.6 3 111 a, b
TBB2C Tubulin beta 2C chain gi|40018568 50.2 2 69 a
For each protein, the number of peptides leading to identiﬁcation by MS/MS is indicated. Proteins in italics were identiﬁed on the basis of a single MS/MS and therefore cannot
be considered as formally identiﬁed. Names, accession numbers (Rattus norvegicus), theoretical molecular weights and Mascot scores are reported (signiﬁcance threshold was
24). a, b and c denote subcellular localization according to [27], [26] or [57], respectively.
Fig. 2. Syt11 interacts directly with SND1. (A) Immunoprecipitation of SND1 were
performed using a guinea pig anti-SND1 antibody. Ago2 was detected by Western
blots, 0.5–3% of the initial INS-1E postnuclear supernatant was loaded on the gel as
comparison. (B) Direct interaction between recombinant syt11C2A or C2B domains
and N-terminal SND1 was investigated by dot-blot and quantiﬁcations are given
(N = 5; ⁄p < 0.05, Bonferroni’s). Fig. 3. Summary of observed interactions. Red arrows, interactions observed by
pull-down and subsequent mass spectrometry and/or immunoblot; Proteins known
to reside at the ERGIC or Golgi are given in bold (see also Table 1), proteins
identiﬁed by one peptide only are given in italics.
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body against Ago2 (Fig. 2A). Clearly SND1 interacts with syt11
and with Ago2. We subsequently asked whether the interaction
between SND1 and syt11 was of direct nature or required other
scaffolding proteins. Full-length SND1 is poorly soluble and we
therefore used a C-terminally truncated recombinant protein com-
prising only the N-terminal four staphylococcus nuclease (SN1-639)
domains fused to GST (GST-SN). As shown in Fig. 2B, GST-SN
(SND1) interacted with GST-Syt11C2B in a dot blot assay, but not
with GST-Syt11C2A. This designates the SN domains and the C2B
domains as minimal directly interacting modules(see Fig. 3).
4. Discussion
The calcium-sensitive synaptotagmins have been extensively
characterized in post-Golgi trafﬁcking [29]. Our study on a cal-
cium-insensitive member, syt11, the vertebrate paralog of syt4
[30], revealed a deﬁned link with the RNA-induced silencing com-
plex RISC, known to be important in regulation of genes by
microRNAs.
Obviously care has to be taken in regard to the speciﬁcity of
protein–protein interactions. To avoid any potential interference
by nucleic acids and electrostatic interactions, we used nucleaseand high-salt treatment. Similarly, we used KCl instead of NaCl
for washes. Moreover, a number of differential interactions were
observed and most importantly, co-localization of binding partners
including most of the ribosomal proteins identiﬁed here could be
deduced from published proteomic data and expression of epi-
tope-tagged proteins [31–33].
Protein interactions of syt11 identiﬁed here exhibited two strik-
ing features. First, a number of them had been assigned previously
to Golgi derived-vesicles or to the ERGIC. Note that epitope-tagged
syt11 localized to the Golgi and to vesicles upon transient expres-
sion in neuroendocrine PC12 cells [33]. Second, the majority of the
interacting proteins is linked to RNA synthesis, translation and
processing (Fig. 2). As to their localization, NCL, NPM1, RS10,
RS18, RS3, RS3A, TBB2C, SET and SND1 had been found on ER-Golgi
vesicles or Golgi membranes by proteomic analysis [31,32].
Strikingly, also FMRP, Ago2 and the Q-SNAREs Vti1a/Vti1b, which
we subsequently identiﬁed as interacting proteins by immunore-
activity, reside on ER and on Golgi structures [32,34–36]. The dif-
ferential binding observed here for the Q-SNAREs Vti1a and Vti1b
underlines C2-domain speciﬁcity in protein–protein interactions.
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tion with Parkin, a component of the E3 ubiquitin ligase complex
present on the ER, the Golgi and derived vesicles [38] or with
amyloid beta precursor protein binding protein 2 [39]. These inter-
actions were described for full-length syt11 and may thus occur
outside C2 domains.
The preponderance of ribosomal or RNA binding proteins
presents a striking feature (EIF3A, EIF3B, NPM1, NCL, RS10, RS13,
RS18, RS3, RS3A, SND1). The involvement of synaptotagmin in
the regulation of mRNA dynamics is not without precedence. The
cytoplasmic RNA binding-protein SYNCRIP interacts with the C2B
domains of several syts including syt11, but not syt4 thus suggest-
ing functional differences between the two paralogs [40]. The
novel interaction of syt11 with the ancestral staphylococcal nucle-
ase domain-containing 1 protein SND1 is of particular interest. This
multifunctional regulator of gene expression has a broad expres-
sion proﬁle [41], is enriched in secretory cells [27] and acts as tran-
scriptional co-activator [42], in RNA editing [43], in the generation
of RISC [28] and is linked to apoptosis [44]. SND1 is generally
regarded as a nuclear and/or cytoplasmic protein and in line with
a number of reports, [26,45,46] we observed only extranuclear
expression in b-cells. The deﬁned architecture of SND1 provides
distinct binding sites and functions [47]. Whereas the C-terminal
Tudor domain ﬂanked by SN regions is involved in regulation of
splicing [48], the N-terminal tandem repeats of SN-like domains
are required to complex co-activators and transcription factors
[42,49], to capture and cleave RNA substrates [50], to link Ago2
within the RISC complex [51] and, as shown here, to bind directly
the C2B domain of syt11. Thus tandem repeats of SN-like domains
are capable to undergo multiple simultaneous interactions. As
syt11 interacts with SND1 but also with Ago2 and FMRP, which
are well characterized as RISC components [28,52], syt11 is linked
to the RISC complex in b-cells. Recent data indicate that Ago2 is
required for the compensatory increase in b-cell mass, as found
during insulin resistance, and plays a role in the maintenance of
the insulin secretory pathway [53,54].
The interaction of RISC components with the transmembrane
protein syt11 indicates the association of RISC with organelles. A
link has been reported between RISC and endosomes or multi-
vesicular bodies (MVB) [55,56] promoting their recruitment or
loading at a strategic site relevant for membrane trafﬁc, recycling,
export or viral entry. Intriguingly data mining (see Table 1) and our
observations suggest that respective components such as SND1
and Ago2 are attached already to membranes earlier in the secre-
tory pathway. Moreover, recent work has shown that RISC is linked
the ER membrane and ERGIC/Golgi may be implicated in recycling
of RISC components in plant and in animal cells [57,58]. In conclu-
sion, our observations indicate a novel interaction between RISC
and a transmembrane protein implicated in intracellular trafﬁc
and suggest an unprecedented function for a member of the syn-
aptotagmin family.
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